Alpine Woods Capital Investors LLC Maintains Position in Teleflex Incorporated (TFX)
Alpine Woods Capital Investors LLC continued to hold its stake in Teleflex Incorporated (NYSE:TFX) during the second quarter, Holdings Channel reports. The firm owned 10,700 shares of the medical technology company’s stock at the end of the second quarter. Alpine Woods Capital Investors LLC’s holdings in Teleflex were worth $2,223,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently bought and sold shares of TFX. Asset Planning Services Ltd. purchased a new stake in Teleflex during the first quarter valued at about $116,000. Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in Teleflex during the first quarter valued at about $155,000. OLD Mutual Customised Solutions Proprietary Ltd. boosted its stake in Teleflex by 200.0% in the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 900 shares of the medical technology company’s stock valued at $174,000 after buying an additional 600 shares during the period. Campbell & CO Investment Adviser LLC bought a new stake in Teleflex during the second quarter valued at $200,000. Finally, Harvey Capital Management Inc. bought a new stake in Teleflex during the second quarter valued at $207,000. Institutional investors and hedge funds own 92.59% of the company’s stock.
Teleflex Incorporated (TFX) opened at 208.89 on Tuesday. The company has a 50-day moving average of $209.49 and a 200-day moving average of $197.69. Teleflex Incorporated has a 12 month low of $136.53 and a 12 month high of $217.97. The stock has a market cap of $9.41 billion, a PE ratio of 39.95 and a beta of 1.05.
Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.91 by $0.13. The company had revenue of $528.60 million for the quarter, compared to the consensus estimate of $518.98 million. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. Teleflex’s revenue was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.89 earnings per share. On average, equities analysts forecast that Teleflex Incorporated will post $8.28 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Stockholders of record on Tuesday, August 15th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.65%. The ex-dividend date of this dividend is Friday, August 11th. Teleflex’s dividend payout ratio is currently 26.00%.
TRADEMARK VIOLATION WARNING: “Alpine Woods Capital Investors LLC Maintains Position in Teleflex Incorporated (TFX)” was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://www.watchlistnews.com/alpine-woods-capital-investors-llc-maintains-position-in-teleflex-incorporated-tfx/1490032.html.
Several research firms have recently weighed in on TFX. Needham & Company LLC restated a “buy” rating on shares of Teleflex in a research report on Friday, August 4th. BidaskClub cut shares of Teleflex from a “hold” rating to a “sell” rating in a research report on Tuesday, August 8th. Deutsche Bank AG restated a “buy” rating and set a $238.00 price objective (up previously from $220.00) on shares of Teleflex in a research report on Wednesday, August 9th. Jefferies Group LLC restated a “buy” rating and set a $253.00 price objective (up previously from $230.00) on shares of Teleflex in a research report on Wednesday, August 9th. Finally, Barclays PLC restated a “buy” rating on shares of Teleflex in a research report on Monday, June 26th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $228.00.
In other news, Director Gretchen R. Haggerty bought 1,000 shares of Teleflex stock in a transaction dated Wednesday, June 21st. The shares were acquired at an average price of $203.82 per share, with a total value of $203,820.00. Following the completion of the purchase, the director now owns 1,760 shares in the company, valued at approximately $358,723.20. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $199.93, for a total transaction of $39,986.00. Following the completion of the sale, the director now directly owns 8,080 shares in the company, valued at approximately $1,615,434.40. The disclosure for this sale can be found here. In the last three months, insiders sold 3,100 shares of company stock worth $637,463. Insiders own 2.39% of the company’s stock.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.